Pharma Deals Review, Vol 2002, No 31 (2002)

Font Size:  Small  Medium  Large

LG Life Sciences to Market Thymitaq® in Republic of Korea

Business Review Editor

Abstract


EXIMIAS Pharmaceutical granted LG Life Sciences the distribution rights to Thymitaq in Korea. Thymitaq is an inhibitor of the enzyme thymidylate synthase and potential anticancer drug.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.